DIN 02443945 — JARDIANCE 25 MG
JARDIANCE is a tablet of Empagliflozin marketed by BOEHRINGER INGELHEIM (CANADA) LTD LTEE. The full Empagliflozin monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02443945
- Brand name
- JARDIANCE
- Active ingredient
- Empagliflozin
- Strength
- 25 MG
- Dosage form
- TABLET
- Route
- ORAL
- Manufacturer
- BOEHRINGER INGELHEIM (CANADA) LTD LTEE
- Health Canada status
- MARKETED
- Drug class
- Sodium-glucose cotransporter-2 (SGLT2) inhibitor
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Empagliflozin products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02443937 | JARDIANCE | 10 MG | TABLET | BOEHRINGER INGELHEIM (CANADA) LTD LTEE | MARKETED |